Position in ANNX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,347,502
+$1,176,777 QoQ
Shares Held
235,990
+665.8% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. ANNX ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,347,502 | 235,990 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $170,725 | 30,817 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $118,672 | 23,640 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $20,824 | 6,828 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $90,710 | 37,796 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $144,101 | 74,664 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $865,876 | 168,787 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $414,435 | 70,006 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,278,873 | 669,158 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $92,341 | 12,879 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $32,024 | 7,054 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,617 | 1,109 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $52,507 | 14,917 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $319,834 | 83,074 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $416,231 | 80,509 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $25,269 | 4,089 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,021 | 1,332 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $28,274 | 10,357 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $733,234 | 63,815 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $156,807 | 8,426 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,031,070 | 45,805 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $877,294 | 31,512 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $107,378 | 4,290 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $21,402 | 708 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||